[Adjuvant therapy of colon cancer. State of the art and future perspectives]

Tumori. 1999 May-Jun;85(3):A1-6. doi: 10.1177/030089169908500315.
[Article in Italian]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma / drug therapy*
  • Carcinoma / pathology
  • Carcinoma / therapy
  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / therapy
  • Fluorouracil / therapeutic use
  • Folic Acid / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use
  • Leucovorin / therapeutic use
  • Levamisole / therapeutic use
  • Methotrexate / therapeutic use
  • Neoplasm Staging
  • Survival Analysis
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Levamisole
  • Folic Acid
  • Leucovorin
  • Fluorouracil
  • Methotrexate